0.5487 USD
-0.04 (-6.56%)
0.5411 USD
-0.01 (-1.39%)
Taking everything into account, FEMY scores 2 out of 10 in our fundamental rating. FEMY was compared to 184 industry peers in the Health Care Equipment & Supplies industry. FEMY may be in some trouble as it scores bad on both profitability and health. FEMY is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year FEMY has reported negative net income.
- In the past year FEMY has reported a negative cash flow from operations.
- In the past 5 years FEMY always reported negative net income.
- In the past 5 years FEMY always reported negative operating cash flow.
1.2 Ratios
- With a Return On Assets value of -121.55%, FEMY is not doing good in the industry: 83.15% of the companies in the same industry are doing better.
- Looking at the Return On Equity, with a value of -434.59%, FEMY is doing worse than 80.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -121.55% | ||
| ROE | -434.59% | ||
| ROIC | N/A |
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- FEMY has a Gross Margin of 63.05%. This is in the better half of the industry: FEMY outperforms 65.76% of its industry peers.
- In the last couple of years the Gross Margin of FEMY has declined.
- The Profit Margin and Operating Margin are not available for FEMY so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.05% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
2. Health
2.1 Basic Checks
- FEMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for FEMY has been increased compared to 1 year ago.
- Compared to 5 years ago, FEMY has more shares outstanding
- FEMY has a worse debt/assets ratio than last year.
2.2 Solvency
- FEMY has an Altman-Z score of -13.19. This is a bad value and indicates that FEMY is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of FEMY (-13.19) is worse than 82.61% of its industry peers.
- FEMY has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
- Looking at the Debt to Equity ratio, with a value of 1.43, FEMY is doing worse than 78.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -13.19 |
ROIC/WACCN/A
WACC9.58%
2.3 Liquidity
- A Current Ratio of 1.16 indicates that FEMY should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.16, FEMY is doing worse than 82.07% of the companies in the same industry.
- FEMY has a Quick Ratio of 1.16. This is a bad value and indicates that FEMY is not financially healthy enough and could expect problems in meeting its short term obligations.
- FEMY has a Quick ratio of 0.61. This is amonst the worse of the industry: FEMY underperforms 89.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
- FEMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.35%, which is quite good.
- The Revenue has grown by 63.54% in the past year. This is a very strong growth!
- FEMY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.86% yearly.
EPS 1Y (TTM)12.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
Revenue 1Y (TTM)63.54%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%31.35%
3.2 Future
- FEMY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.28% yearly.
- The Revenue is expected to grow by 97.39% on average over the next years. This is a very strong growth
EPS Next Y33.6%
EPS Next 2Y24.9%
EPS Next 3Y18.64%
EPS Next 5Y15.28%
Revenue Next Year-2.37%
Revenue Next 2Y55.35%
Revenue Next 3Y100.14%
Revenue Next 5Y97.39%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- FEMY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FEMY. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- FEMY's earnings are expected to grow with 18.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.9%
EPS Next 3Y18.64%
5. Dividend
5.1 Amount
- No dividends for FEMY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FEMASYS INC / FEMY FAQ
What is the ChartMill fundamental rating of FEMASYS INC (FEMY) stock?
ChartMill assigns a fundamental rating of 2 / 10 to FEMY.
What is the valuation status of FEMASYS INC (FEMY) stock?
ChartMill assigns a valuation rating of 0 / 10 to FEMASYS INC (FEMY). This can be considered as Overvalued.
Can you provide the profitability details for FEMASYS INC?
FEMASYS INC (FEMY) has a profitability rating of 1 / 10.